| 臺大學術典藏 |
2021-07-03T03:34:17Z |
Antiviral therapy and hepatitis B virus-related hepatocellular carcinoma recurrence [2]
|
Yeh Y.-C.; PEI-JER CHEN; Lai M.-S. |
| 臺大學術典藏 |
2020-03-04T07:45:19Z |
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism
|
Su T.-H.; Yang H.-C.; Tseng T.-C.; Chou S.-W.; CHIN-HSIEN LIN; Liu C.-H.; Liu C.-J.; Chen C.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:26Z |
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism
|
Su T.-H; | HUNG-CHIH YANG; | Tseng T.-C; | Chou S.-W; | Lin C.-H; | Liu C.-H; | Liu C.-J; | Chen C.-L; | Kao J.-H. |
| 臺大學術典藏 |
2019 |
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism
|
Su T.-H.;Yang H.-C.;Tseng T.-C.;Chou S.-W.;Chin-Hsien Lin;Liu C.-H.;Liu C.-J.;Chen C.-L.;Kao J.-H.; Su T.-H.; Yang H.-C.; Tseng T.-C.; Chou S.-W.; CHIN-HSIEN LIN; Liu C.-H.; Liu C.-J.; Chen C.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:15Z |
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism
|
TUNG-HUNG SU; Yang H.-C.; Tseng T.-C.; Chou S.-W.; Lin C.-H.; Liu C.-H.; Liu C.-J.; Chen C.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:20Z |
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism
|
Su T.-H.; Yang H.-C.; Tseng T.-C.; Chou S.-W.; Lin C.-H.; CHEN-HUA LIU; Liu C.-J.; Chen C.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T05:16:45Z |
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism
|
Su T.-H.; Yang H.-C.; Tseng T.-C.; Chou S.-W.; Lin C.-H.; Liu C.-H.; Liu C.-J.; Chen C.-L.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-24T09:31:12Z |
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism
|
Su T.-H.; Yang H.-C.; Tseng T.-C.; Chou S.-W.; Lin C.-H.; Liu C.-H.; CHUN-JEN LIU; Chen C.-L.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:03Z |
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism
|
Su T.-H.; Yang H.-C.; Tseng T.-C.; Chou S.-W.; Lin C.-H.; Liu C.-H.; Liu C.-J.; CHI-LING CHEN; Kao J.-H. |
| 國家衛生研究院 |
2023-09-02 |
Antiviral therapy of coronavirus disease 2019 (COVID-19)
|
Chen, PY;Wang, JT;Chang, SC |
| 臺大學術典藏 |
2020-03-10T03:29:42Z |
Antiviral treatment for hepatitis B in infancy: Still an issue for debate
|
HUEY-LING CHEN; Ni Y.-H.; Chen P.-J.; Chang M.-H. |
| 臺大學術典藏 |
2020-12-28T08:14:03Z |
Antiviral treatment for hepatitis B in infancy: Still an issue for debate
|
Chang M.-H.; Chen P.-J.; YEN-HSUAN NI; Chen H.-L. |
| 臺大學術典藏 |
2021-01-04T07:32:10Z |
Antiviral treatment for hepatitis B in infancy: Still an issue for debate
|
Chen H.-L.; Ni Y.-H.; Chen P.-J.; MEI-HWEI CHANG |
| 臺大學術典藏 |
2021-07-03T03:33:30Z |
Antiviral treatment for hepatitis B in infancy: Still an issue for debate
|
Chen H.-L.;Ni Y.-H.;Pei-Jer Chen;Chang M.-H.; Chen H.-L.; Ni Y.-H.; PEI-JER CHEN; Chang M.-H. |
| 義守大學 |
2014-04 |
Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients
|
Yao-Chun Hsu;Jaw-Town Lin;Hsiu J. Ho;Yu-Hsi Kao;Yen-Tsung Huang;Nai-Wan Hsiao;Ming-Shiang Wu;Yi-Ya Liu;Chun-Ying Wu |
| 中國醫藥大學 |
2014-04 |
Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients
|
許耀峻(Yao-Chun Hsu);林肇堂(Jaw-Town Lin);何秀榮(Hsiu J. Ho);(Yu-Hsi Kao);(Yen-Tsung Huang);蕭乃文(Nai-Wan Hsiao);吳明賢(Ming-Shiang Wu);劉宜雅(Yi-Ya Liu);吳俊穎(Chun-Ying Wu)* |
| 臺大學術典藏 |
2018-09-10T14:50:34Z |
Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients
|
Hsu, Y.-C. and Lin, J.-T. and Ho, H.J. and Kao, Y.-H. and Huang, Y.-T. and Hsiao, N.-W. and Wu, M.-S. and Liu, Y.-Y. and Wu, C.-Y.; MING-SHIANG WU |
| 臺大學術典藏 |
2020-11-02T02:04:41Z |
Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients
|
Liu Y.-Y.; Wu C.-Y.; Hsiao N.-W.; MING-SHIANG WU; Huang Y.-T.; Kao Y.-H.; Ho H.J.; Lin J.-T.; Hsu Y.-C. |
| 臺大學術典藏 |
2021-02-02T02:21:28Z |
Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients
|
Hsu Y.-C.; Lin J.-T.; Ho H.J.; Kao Y.-H.; Huang Y.-T.; Hsiao N.-W.; MING-SHIANG WU; Liu Y.-Y.; Wu C.-Y. |
| 臺大學術典藏 |
2022-09-06T07:43:02Z |
Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients
|
Hsu Y.-C.; Lin J.-T.; Ho H.J.; Kao Y.-H.; Huang Y.-T.; Hsiao N.-W.; MING-SHIANG WU; Liu Y.-Y.; Wu C.-Y. |
| 國家衛生研究院 |
2014-04 |
Antiviral treatment for Hhepatitis C Virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients
|
Hsu, YC;Lin, JT;Ho, HJ;Kao, YH;Huang, YT;Hsiao, NW;Wu, MS;Liu, YY;Wu, CY |
| 臺大學術典藏 |
2020-07-15T00:49:54Z |
Antivirals and vaccines for Enterovirus A71
|
JING-YI LIN; Kung Y.-A.; Shih S.-R. |
| 國立臺灣海洋大學 |
2012-01 |
Antivirus and prebiotic properties of seaweed-oligosaccharide lysates derived from agarase AS-II
|
Shao-Chi Wu;Sheen-Kye Kang;Bartosz Kazłowski;Chang-Jer Wu;Chorng-Liang Pan |
| 國立臺灣海洋大學 |
2012-01 |
Antivirus and prebiotic properties of seaweed-oligosaccharide-lysates derived from agarase AS-II
|
Shao-Chi Wu; Sheen-Kye Kang; Bartosz Kazłowski; Chorng-Liang Pan |
| 臺大學術典藏 |
2020-05-04T08:06:41Z |
Antiwear Leveling Design for SSDs With Hybrid ECC Capability
|
Ho, Chien-Chung;Liu, Yu-Ping;Chang, Yuan-Hao;Kuo, Tei-Wei; Ho, Chien-Chung; Liu, Yu-Ping; Chang, Yuan-Hao; Kuo, Tei-Wei; TEI-WEI KUO |
